A firm in Western Europe has supported over 80 companies and actively works as an active collaborator in the life sciences industry by the means of co-creation of companies, capital acquisition, and more. The firm has a network of hospitals in which allows the firm to help companies better develop health products that meet patient needs. Notably, it has organized an operational team of Experts and Entrepreneurs in residence enabling hands-on activities. When investing, the firm will likely combine between €2-7M, depending on the company’s needs, and focuses on partnering with seed and early venture stage companies. The firm is open to working with companies beyond Western Europe, including USA, Canada, and other geographies with sizable markets.
The firm is most interested in medical devices and diagnostics companies. While the firm is agnostic in terms of stage of development or disease areas/indications, the firm is seeking technologies that can be implemented in hospital systems in the short term (~4-5 years). The firm is also open to digital health technologies but stays away from traditional therapeutics.
The firm seeks to work with experienced, dedicated management teams. The firm seeks to be a very active, hands-on partner with all companies they work with, assisting companies with services such as operations, management team support, etc. As an active health innovation integrator, the firm also helps organize regular networking events to foster new connections and collaborations among their network of entrepreneurs, investors, industry partners, and more. The firm can act as a lead or co-investor depending on the deal.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment